The customer observed a falsely elevated cyclosporine result for one patient on the architect i1000sr analyzer.The following data was provided: initial 1300 ug/l (suspect falsely elevated, questioned by the doctor).1:4 dilution and obtained <800 ug/l with a cnrl flag, repeated the sample neat 1000 ug/l.1:4 dilution 50 ug/l (the dilution factor was not keyed in however), there was no impact to patient management reported.
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, a review of labeling and accuracy testing.No adverse trend was identified for the customer's issue.Labeling was reviewed and found to be adequate.The product was not available for return.Accuracy testing of the reagent lot with two levels of an internal panel (each level contains a known concentration of the cyclosporine analyte) met all specifications.Complaint information reasonably suggests the assay is performing as intended, and no malfunction of the device occurred.Based on the available information, no product deficiency was identified.
|